TNF Pharmaceuticals, Inc.
TNFA
$0.22
$0.02814.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.52M | 10.64M | 13.07M | 1.74M | 4.92M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 893.70K | 1.39M | 1.29M | 725.20K | 893.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.41M | 12.03M | 14.36M | 2.46M | 5.82M |
|
|
|||||
| Total Current Assets | 9.41M | 12.03M | 14.36M | 2.46M | 5.82M |
| Net Property, Plant & Equipment | 10.60K | 18.30K | 25.80K | 34.90K | 47.40K |
| Long-term Investments | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Goodwill | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 21.42M | 24.04M | 26.38M | 14.49M | 17.86M |
|
|
|||||
| Total Accounts Payable | 2.52M | 3.71M | 4.09M | 3.35M | 3.08M |
| Total Accrued Expenses | 386.70K | 455.20K | 524.40K | 511.00K | 637.10K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.60K | 18.30K | 25.80K | 36.00K | 48.90K |
| Total Finance Division Other Current Liabilities | 3.79M | 2.81M | 1.14M | 75.80K | 1.22M |
| Total Other Current Liabilities | 3.79M | 2.81M | 1.14M | 75.80K | 1.22M |
| Total Current Liabilities | 6.70M | 6.99M | 5.78M | 3.97M | 4.99M |
|
|
|||||
| Total Current Liabilities | 6.70M | 6.99M | 5.78M | 3.97M | 4.99M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 20.22M | 279.60K | 100.50K |
| Total Liabilities | 6.70M | 6.99M | 26.00M | 4.25M | 5.09M |
|
|
|||||
| Common Stock & APIC | 138.78M | 142.64M | 123.28M | 122.77M | 114.20M |
| Retained Earnings | -129.14M | -126.00M | -123.32M | -112.98M | -101.98M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 9.65M | 16.63M | -46.70K | 9.79M | 12.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 5.07M | 422.20K | 429.00K | 447.90K | 548.60K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.07M | 422.20K | 429.00K | 447.90K | 548.60K |
|
|
|||||
| Total Common Equity | 9.65M | 16.63M | -46.70K | 9.79M | 12.23M |
| Total Preferred Equity | 5.07M | 422.20K | 429.00K | 447.90K | 548.60K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.72M | 17.06M | 382.30K | 10.24M | 12.77M |
|
|
|||||